[-] Show simple item record

dc.contributor.authorTait, Joyceeng
dc.date.issued2001eng
dc.description.abstractZeneca's agrochemical strategies had two major strands: developing the profit potential from existing patented and off-patent chemicals where this was feasible; and major investment in discovery of new, patented products. In developing genetically modified (GM) crops, managers were mainly focusing on output rather than input characteristics. The new "whole crop strategy" was based on an understanding that agrobiotechnology markets are likely to be based on a combination of chemicals and transgenic methodology, and included the assumption that GM-based output traits would enhance the economic value of the crop, increasing the demand for effective crop protection from a combination of chemicals and GM input traits.eng
dc.description.bibrefIncludes bibliographical referenceseng
dc.identifier.citationAgBioForum, 4(1) 2001: 63-67.eng
dc.identifier.issn1522-936Xeng
dc.identifier.urihttp://hdl.handle.net/10355/352
dc.languageEnglisheng
dc.publisherAgBioForumeng
dc.relation.ispartofcollectionAgBioForum, vol. 4, no. 1 (2001)eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.
dc.source.urihttp://www.agbioforum.missouri.edu/v4n1/v4n1a11-tait.htmeng
dc.subjectsustainable developmenteng
dc.subjectagrochemical strategieseng
dc.subject.lcshZeneca Pharmaceuticalseng
dc.subject.lcshAgricultural chemicalseng
dc.subject.lcshAgricultural chemicals industryeng
dc.subject.meshCrops -- Genetic engineeringeng
dc.titleZeneca Agrochemicalseng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record